List of Primer Oligos for Qpcr Analysis Gene Forward
Total Page:16
File Type:pdf, Size:1020Kb
SUPPLEMENTARY DATA Supplementary Table 1: List of Primer Oligos for qPCR analysis Gene Forward (5’->3’) Reverse (5’->3’) HPRT1 GAAAAGGACCCCACGAAGTGT AGTCAAGGGCATATCCTACAA B2M TGTCTTTCAGCAAGGACTGG AGCAAGCAAGCAGAATTTGG RPLP0 TGTTTCATTGTGGGAGCAGA GAACACAAAGCCCACATTCC GAPDH TGCACCACCAACTGCTTAGC GGCATGGACTGTGGTCATGAG DAPK3 AATCTGAGGAGCTGGGTTGC TCCAGGGAAAGTGCAGTCAC ATP2A3 AGTGCTCCGAAGACAACCC GTTCTCCGAGACGCTGTTG PPIB ATGTAGGCCGGGTGATCTTT CATCTCCCCTGGTGAAGTCT TBP AGTTCTGGGATTGTACCGCA TATATTCGGCGTTTCGGGCA mRNA was harvested from cultured myotubesusing a kit (E.Z.N.A. Total RNA Kit 1, Omega bio-tek, Norcross, GA). Reverse transcription and quantitative PCR were carried out using MultiScribe Reverse Transcriptase and Fast SYBR Green Master Mix, respectively (Thermo Fisher Scientific). Gene expression of ATP2A3, DAPK3, and reference genes (PPIB, TBP) was assessed using self-designed oligonucleotides (Sigma-Aldrich). ©2016 American Diabetes Association. Published online at http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db16-0882/-/DC1 SUPPLEMENTARY DATA Supplementary Table 2: List of Antibodies used for Western-blot analysis Target Vendor Product Number PKB p-Thr-308 Cell Signaling (Danvers, MA) 4056 PKB total Cell Signaling 9272 TBC1D4 p-Ser-318 Cell Signaling 8619 TBC1D4 total Merck Millipore (Billerica, MA) 07-741 p62 Sigma-Aldrich P0067 LC3 Sigma-Aldrich L8918 GAPDH Santa Cruz Biotechnology (Dallas, TX) sc-257758 Myotube lysates were diluted in Laemmli buffer (60 mMtris base at pH 6.8, 2% w/v SDS, 10% v/v glycerol, 0.01% w/v bromophenol blue, 1.25% v/v β-mercaptoethanol). SDS-PAGE was conducted using pre-cast tris-HCl and tris-bis gels with tris/glycine/SDS or 2-(N-morpholino)ethanesulfonic acid running buffers, respectively (Bio-Rad). Proteins were transferred to Immobilon-P PVDF membranes (Merck Millipore). Equal loading of protein between samples was assessed by Ponceau staining (Sigma- Aldrich) or fluorescent-detection in the case of stain-free gels (Bio-Rad). Membranes were washed in tris-buffered saline (TBS) with Tween-20 (Sigma-Aldrich) (TBST) (20 mMtris at pH 7.6, 137 mMNaCl, 0.02% v/v Tween-20). Membranes were blocked in 7.5% non-fat dry milk, washed again in TBST, then incubated with primary antibodies overnight at 4°C (1:1000 in TBS with 0.1% w/v bovine serum albumin, 0.1% w/v NaN3). Membranes were washed again in TBST, incubated with horseradish peroxidase-conjugated secondary antibodies (1:25000 in TBST with 4% NFDM; Thermo Fisher Scientific) for 1-2 hours at room temperature and then washed in TBST. Immunolabeled bands were visualized using extended chemiluminescence reagents (GE Healthcare) and autoradiograms were quantitated by scanning densitometry using Image Lab software (Bio-Rad). ©2016 American Diabetes Association. Published online at http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db16-0882/-/DC1 SUPPLEMENTARY DATA Supplementary Table 3: t-tests (unpaired & paired, 2-sided Gene Name RELATION_TO_ M value Beta value name of the UCSC_CPG_ISLA target_ID difference difference p_unpaired p_paired closest gene UCSC_REFGENE_GROUP UCSC_CPG_ISLANDS_NAME ND cg03312587 -0.2728 0.0361 0.0122 0.0207 A2BP1 5'UTR;5'UTR;5'UTR cg20307184 0.6291 -0.0475 0.0287 0.0113 ABCA13 Body cg07372195 0.9867 -0.0462 0.0111 0.0239 ABCA5 5'UTR;1stExon;5'UTR cg14647845 0.4657 -0.0323 0.0181 0.0040 ABLIM2 Body;Body;Body;Body;Body;Body;Body cg20497635 1.0417 -0.0930 0.0345 0.0094 ABR Body;Body;Body cg13686847 -0.4127 0.0310 0.0203 0.0239 ACACB Body cg06698843 -0.5306 0.0403 0.0314 0.0164 ACADS Body chr12:121177115-121177341 N_Shelf cg07343187 -0.8390 0.0336 0.0399 0.0498 ACAN Body;Body cg16380285 -0.6346 0.0318 0.0106 0.0139 ACAP3 3'UTR chr1:1228780-1230163 N_Shore cg04854749 -0.2989 0.0420 0.0002 0.0006 ACIN1 Body;Body;Body;Body;Body chr14:23528360-23528582 S_Shore cg22402043 0.7627 -0.0487 0.0272 0.0044 ACP6 Body chr1:147141842-147142918 N_Shelf cg17541674 -0.3461 0.0661 0.0095 0.0113 ACPT Body chr19:51294876-51295098 S_Shore TSS1500;TSS1500;TSS1500;TSS1500;TSS150 cg07665222 0.5427 -0.0509 0.0032 0.0095 ACRV1 0;TSS1500;TSS1500;TSS1500;TSS1500 cg04252928 0.4396 -0.0412 0.0491 0.0049 ACSF3 Body;Body;Body chr16:89167116-89167482 S_Shore cg02009395 0.3747 -0.0423 0.0490 0.0246 ACSM1 TSS200 cg03369957 0.5781 -0.0794 0.0448 0.0469 ACTL6B Body chr7:100253782-100254150 N_Shore cg18862171 0.7014 -0.0449 0.0088 0.0009 ACTN3 TSS200;TSS1500 chr11:66314207-66314455 Island cg04738270 0.7167 -0.0537 0.0053 0.0172 ACTR1A Body chr10:104262224-104262524 N_Shore cg21577356 -0.4103 0.0406 0.0038 0.0046 ACTR3C TSS1500;5'UTR;5'UTR chr7:150019950-150020752 S_Shore cg04892170 0.7435 -0.0300 0.0232 0.0108 ADAM12 1stExon;5'UTR;5'UTR;1stExon chr10:128076155-128077482 Island cg05847038 0.7683 -0.0500 0.0405 0.0247 ADAM7 Body cg16451601 0.7209 -0.0577 0.0234 0.0446 ADAMTS2 Body;Body cg01260219 -0.3110 0.0414 0.0019 0.0295 ADAMTS8 TSS1500 chr11:130297401-130298517 S_Shore cg21170978 0.7111 -0.0340 0.0454 0.0314 ADAMTSL1 Body cg01629749 0.4718 -0.0651 0.0323 0.0262 ADAP1 Body chr7:959724-959959 Island cg04233620 -0.8087 0.0847 0.0106 0.0195 ADARB1 Body;Body;Body;Body;Body;Body;Body cg00615654 0.8293 -0.0706 0.0081 0.0201 ADARB2 Body chr10:1382500-1383006 N_Shore cg11637718 -0.4758 0.0424 0.0004 0.0063 ADCY9 Body chr16:4029157-4029413 Island ©2016 American Diabetes Association. Published online at http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db16-0882/-/DC1 SUPPLEMENTARY DATA cg16230755 -0.3191 0.0309 0.0243 0.0312 ADD3 5'UTR;5'UTR;5'UTR cg05727225 -0.3990 0.0446 0.0207 0.0274 ADM Body chr11:10327013-10329831 Island cg25320816 -0.3776 0.0529 0.0130 0.0168 ADPRHL1 5'UTR;Body chr13:114096050-114096317 S_Shelf cg11367939 -0.4440 0.0361 0.0099 0.0220 ADRA2A 3'UTR;1stExon chr10:112835990-112839303 Island cg22275864 0.7223 -0.0492 0.0303 0.0395 ADRB3 Body chr8:37822486-37824008 Island cg16389474 0.5792 -0.0369 0.0241 0.0009 ADRM1 5'UTR;5'UTR chr20:60877499-60879008 Island cg10028549 -0.3009 0.0419 0.0319 0.0136 AFAP1 TSS1500;TSS1500 chr4:7940563-7941853 S_Shore cg02441982 0.6113 -0.0419 0.0234 0.0015 AFMID Body;TSS1500;Body;Body chr17:76183077-76183449 S_Shore cg27436044 -0.3079 0.0301 0.0104 0.0095 AGA Body chr4:178363239-178363708 N_Shelf cg13018278 -0.1426 0.0359 0.0461 0.0030 AGAP1 Body;Body chr2:237028848-237029121 Island cg22199080 -0.5048 0.0814 0.0437 0.0293 AGAP2 1stExon chr12:58130870-58132047 S_Shelf cg01338043 -0.4313 0.0608 0.0176 0.0379 AGFG2 TSS1500 chr7:100136448-100136919 N_Shore cg20352108 0.5140 -0.0536 0.0270 0.0010 AGPAT4 5'UTR cg03120284 -0.8278 0.0888 0.0464 0.0191 AGRN Body chr1:990274-990694 N_Shelf cg09745307 0.5330 -0.0353 0.0040 0.0250 AGXT2 TSS1500 cg04911680 0.5029 -0.0316 0.0216 0.0013 AHDC1 5'UTR chr1:27894927-27895524 Island cg21267167 0.3733 -0.0387 0.0094 0.0034 AJAP1 Body;Body cg17181543 0.5245 -0.0303 0.0451 0.0229 AK5 TSS1500 chr1:77747314-77748224 N_Shore cg27090975 0.2071 -0.0339 0.0223 0.0156 AKAP8L Body chr19:15512025-15512393 S_Shelf cg24455383 -0.3794 0.0748 0.0257 0.0052 AKT3 Body;Body cg14469290 1.0575 -0.1133 0.0332 0.0092 ALAD TSS1500 chr9:116163208-116163848 S_Shore cg16086130 -0.9008 0.0976 0.0047 0.0043 ALDH1A3 TSS1500 chr15:101419261-101421133 Island cg02946394 -0.3862 0.0407 0.0423 0.0431 ALOXE3 Body;Body chr17:8012474-8012846 N_Shore cg11441891 0.7929 -0.0395 0.0192 0.0019 ALS2CL TSS1500;Body cg02562052 1.6860 -0.1228 0.0044 0.0270 ALS2CR4 TSS200;TSS1500 chr2:202507139-202508270 S_Shore cg16893614 0.7877 -0.0554 0.0199 0.0398 ALX3 TSS1500 chr1:110610265-110613303 S_Shore cg00268840 -1.0339 0.0505 0.0249 0.0359 ALX4 TSS1500 chr11:44332314-44332757 Island cg21101750 0.6357 -0.0596 0.0334 0.0231 AMBRA1 TSS1500 chr11:46615197-46615664 N_Shore cg01636354 -0.4430 0.0731 0.0046 0.0421 AMOTL2 Body chr3:134080390-134080596 N_Shore cg12756093 -0.4006 0.0754 0.0015 0.0065 AMPD1 TSS1500 cg24435741 -0.4782 0.0454 0.0246 0.0204 AMPD3 TSS1500 chr11:10472000-10472857 N_Shore Body;5'UTR;1stExon;3'UTR;1stExon;1stExon cg02251567 -0.3202 0.0745 0.0044 0.0271 AMT ;5'UTR;5'UTR;1stExon;5'UTR ©2016 American Diabetes Association. Published online at http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db16-0882/-/DC1 SUPPLEMENTARY DATA cg01186212 0.6372 -0.0340 0.0421 0.0175 ANK3 Body cg14455319 0.2916 -0.0431 0.0375 0.0181 ANKK1 Body chr11:113258443-113258821 S_Shore cg04035353 -0.6295 0.0497 0.0055 0.0178 ANKRD11 Body chr16:89334574-89335088 S_Shore cg13718961 0.3988 -0.0332 0.0200 0.0188 ANKRD13B Body chr17:27939298-27940770 N_Shore cg01635821 0.5661 -0.0347 0.0476 0.0114 ANKRD46 5'UTR chr8:101571515-101572104 N_Shore cg00515408 0.6839 -0.0569 0.0034 0.0258 ANKS1B 5'UTR;1stExon chr12:100378243-100378582 N_Shore cg14938313 -0.4778 0.0431 0.0337 0.0176 ANO1 Body;Body cg15476875 0.6279 -0.0463 0.0054 0.0222 ANO4 Body cg00363845 0.5519 -0.0836 0.0162 0.0446 ANO8 TSS1500 chr19:17443965-17444633 S_Shore cg05998672 0.4527 -0.0316 0.0426 0.0030 AP2A2 Body cg01632240 -0.1981 0.0307 0.0155 0.0067 AP3M2 TSS1500;TSS1500 chr8:42009723-42011098 N_Shore cg14907738 0.3881 -0.0316 0.0092 0.0207 APC2 Body chr19:1456077-1456347 Island cg03624661 -0.7388 0.0314 0.0005 0.0159 APH1B TSS1500;TSS1500 chr15:63569296-63570100 Island cg16353361 -0.5892 0.0507 0.0143 0.0123 APLN TSS1500 chrX:128788003-128789195 S_Shore cg13880303 0.4886 -0.1007 0.0280 0.0195 APOC1 TSS200 cg20691580 -0.5979 0.0348 0.0093 0.0495 APOC3 5'UTR cg04006839 -0.5281 0.0373 0.0152 0.0237 APOH 1stExon cg19599611 0.5928 -0.0369 0.0274 0.0423 AQR 3'UTR cg09120188 0.6820 -0.0357 0.0227 0.0275 ARHGAP23 Body cg15368044 -0.2989 0.0409 0.0408 0.0050